{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidyofn2jp2pzxm4p4nq3af3z3obg4n65la5bh5v53vunt5dsrbgze",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mpqyyoyosf62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif7exzpct6flmi7gsxxlvo4z4dwo5vxevi2bsyclkhtw7fni5wcnu"
    },
    "mimeType": "image/jpeg",
    "size": 125216
  },
  "path": "/news/2026-07-ai-tool-cancer-immunotherapy-drugs.html",
  "publishedAt": "2026-07-03T11:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a knowledge gap that has detrimental effects on patient prognosis, clinical trial recruitment and research that could lead to new therapies.",
  "title": "AI tool improves prediction of who will respond to cancer immunotherapy drugs"
}